These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 28800253

  • 21. Nitric Oxide-Dependent Feedback Loop Regulates Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Cooperativity and Endothelial Function in Small Pulmonary Arteries.
    Marziano C, Hong K, Cope EL, Kotlikoff MI, Isakson BE, Sonkusare SK.
    J Am Heart Assoc; 2017 Dec 23; 6(12):. PubMed ID: 29275372
    [Abstract] [Full Text] [Related]

  • 22. Absence of the calcium-binding protein, S100A1, confers pulmonary hypertension in mice associated with endothelial dysfunction and apoptosis.
    Teichert-Kuliszewska K, Tsoporis JN, Desjardins JF, Yin J, Wang L, Kuebler WM, Parker TG.
    Cardiovasc Res; 2015 Jan 01; 105(1):8-19. PubMed ID: 25395393
    [Abstract] [Full Text] [Related]

  • 23. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J, Thuillet R, Tu L, Phan C, Cumont A, Marsol C, Huertas A, Savale L, Hibert M, Galzi JL, Bonnet D, Humbert M, Frossard N, Guignabert C.
    Cardiovasc Res; 2020 Mar 01; 116(3):686-697. PubMed ID: 31173066
    [Abstract] [Full Text] [Related]

  • 24. Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling.
    Dumas de la Roque E, Smeralda G, Quignard JF, Freund-Michel V, Courtois A, Marthan R, Muller B, Guibert C, Dubois M.
    PLoS One; 2017 Mar 01; 12(2):e0173044. PubMed ID: 28235094
    [Abstract] [Full Text] [Related]

  • 25. Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.
    Tian W, Jiang X, Tamosiuniene R, Sung YK, Qian J, Dhillon G, Gera L, Farkas L, Rabinovitch M, Zamanian RT, Inayathullah M, Fridlib M, Rajadas J, Peters-Golden M, Voelkel NF, Nicolls MR.
    Sci Transl Med; 2013 Aug 28; 5(200):200ra117. PubMed ID: 23986401
    [Abstract] [Full Text] [Related]

  • 26. PAI-1 deficiency drives pulmonary vascular smooth muscle remodeling and pulmonary hypertension.
    Kudryashova TV, Zaitsev SV, Jiang L, Buckley BJ, McGuckin JP, Goncharov D, Zhyvylo I, Lin D, Newcomb G, Piper B, Bogamuwa S, Saiyed A, Teos L, Pena A, Ranson M, Greenland JR, Wolters PJ, Kelso MJ, Poncz M, DeLisser HM, Cines DB, Goncharova EA, Farkas L, Stepanova V.
    Am J Physiol Lung Cell Mol Physiol; 2024 Sep 01; 327(3):L319-L326. PubMed ID: 38860847
    [Abstract] [Full Text] [Related]

  • 27. The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.
    Batool M, Berghausen EM, Zierden M, Vantler M, Schermuly RT, Baldus S, Rosenkranz S, Ten Freyhaus H.
    Basic Res Cardiol; 2020 Nov 13; 115(6):68. PubMed ID: 33188479
    [Abstract] [Full Text] [Related]

  • 28. Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.
    Peng G, Ivanovska J, Kantores C, Van Vliet T, Engelberts D, Kavanagh BP, Enomoto M, Belik J, Jain A, McNamara PJ, Jankov RP.
    Am J Physiol Heart Circ Physiol; 2012 Jun 15; 302(12):H2599-611. PubMed ID: 22505643
    [Abstract] [Full Text] [Related]

  • 29. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
    Chen J, Wang YX, Dong MQ, Zhang B, Luo Y, Niu W, Li ZC.
    J Am Heart Assoc; 2017 Jun 23; 6(6):. PubMed ID: 28645933
    [Abstract] [Full Text] [Related]

  • 30. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.
    Oka M, Karoor V, Homma N, Nagaoka T, Sakao E, Golembeski SM, Limbird J, Imamura M, Gebb SA, Fagan KA, McMurtry IF.
    Cardiovasc Res; 2007 Jun 01; 74(3):377-87. PubMed ID: 17346686
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC, van Zuijen I, Huang CJ, Szulcek R, Pan X, van Dinther MA, Kurakula K, Wiesmeijer CC, Goumans MJ, Bogaard HJ, Morrell NW, Rana AA, Ten Dijke P.
    J Pathol; 2019 Nov 01; 249(3):356-367. PubMed ID: 31257577
    [Abstract] [Full Text] [Related]

  • 33. Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.
    Fijalkowska I, Xu W, Comhair SA, Janocha AJ, Mavrakis LA, Krishnamachary B, Zhen L, Mao T, Richter A, Erzurum SC, Tuder RM.
    Am J Pathol; 2010 Mar 01; 176(3):1130-8. PubMed ID: 20110409
    [Abstract] [Full Text] [Related]

  • 34. Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target.
    Satoh T, Satoh K, Yaoita N, Kikuchi N, Omura J, Kurosawa R, Numano K, Al-Mamun E, Siddique MA, Sunamura S, Nogi M, Suzuki K, Miyata S, Morser J, Shimokawa H.
    Circ Res; 2017 Apr 14; 120(8):1246-1262. PubMed ID: 28289017
    [Abstract] [Full Text] [Related]

  • 35. Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells.
    Shan X, Gegentuya, Wang J, Feng H, Zhang Z, Zheng Q, Zhang Q, Yang K, Wang J, Xu L.
    Am J Physiol Cell Physiol; 2023 Oct 01; 325(4):C1058-C1072. PubMed ID: 37661916
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction.
    Weerackody RP, Welsh DJ, Wadsworth RM, Peacock AJ.
    Am J Physiol Heart Circ Physiol; 2009 May 01; 296(5):H1312-20. PubMed ID: 19201999
    [Abstract] [Full Text] [Related]

  • 38. Quaternary ammonium salt of U50,488H elicits protective effects against hypoxic pulmonary hypertension.
    Zhou Y, Tian X, Wang X, Wang Y, Fan R, Wang Y, Feng N, Zhang S, Guo H, Gu X, Jia M, Yin W, Hou Z, Li J, Pei J.
    Eur J Pharmacol; 2018 Aug 05; 832():129-137. PubMed ID: 29782857
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats.
    Mam V, Tanbe AF, Vitali SH, Arons E, Christou HA, Khalil RA.
    J Pharmacol Exp Ther; 2010 Feb 05; 332(2):455-62. PubMed ID: 19915069
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.